DOR BIOPHARMA INC has a total of 14 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AZAYA THERAPEUTICS INC, CURADIS GMBH and SCOPHYSA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Liang Likan | 7 |
#2 | Constantinides Panayiotis P | 4 |
#3 | Jang Eun-Hyun | 4 |
#4 | Mcdonald George B | 4 |
#5 | Kanzer Steve | 4 |
#6 | Stergiopoulos Nicholas | 4 |
#7 | Constantinides Panos P | 3 |
#8 | Patil Reena T | 3 |
#9 | Bolotin Elijah M | 2 |
#10 | Epstein Joel B | 1 |
Publication | Filing date | Title |
---|---|---|
AU2002360547A1 | Monoterpene compositions and uses thereof | |
AU2002353118A1 | Lipid particles and suspensions and uses thereof | |
EP1460992A2 | Stabilized reverse micelle compositions and uses thereof | |
AU2002362040A8 | Reverse micelle compositions and uses thereof | |
US7323471B1 | Topical azathioprine for the treatment of oral autoimmune diseases |